E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/24/2006 in the Prospect News Biotech Daily.

Worldwide Biotech buys 51% stake in Hunan Hua Yang Pharmaceutical

By Ted A. Knutson

Washington, Jan. 24 - Worldwide Biotech and Pharmaceutical Co. said it has acquired a 51% stake in Hunan Hua Yang Pharmaceutical Co. Ltd.

Worldwide will issue 482,000 shares to Hunan Hua's previous owners as payment.

In addition, Worldwide subsidiary Yangling Daiying Biotech & Pharmaceutical Group Co. Ltd. is paying $174,000 for an 18% stake in Hunan Ze An Pharmaceutical Co. Ltd.

Worldwide Biotech is a Sarasota, Fla.-based biotechnology company.

The announcement was made in an 8-K filing with the Securities and Exchange Commission.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.